Advertisement
Wednesday, Dec 01, 2021
Outlook.com
Outlook.com

Johnson & Johnson Hopeful About Getting EUA Of It's Single-Dose COVID Vaccine In India

'On August 5, 2021 Johnson & Johnson Pvt Ltd applied for EUA of its single-dose COVID-19 vaccine to the government of India,' a Johnson & Johnson India spokesperson said in a statement.

Johnson & Johnson Hopeful About Getting EUA Of It's Single-Dose COVID Vaccine In India
Representational Image | AP
Johnson & Johnson Hopeful About Getting EUA Of It's Single-Dose COVID Vaccine In India
outlookindia.com
2021-08-06T14:43:36+05:30

Johnson & Johnson, the global healthcare major announced that it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India.

Earlier on Monday, the company had said that they are hopeful about getting the Emergency Use Authorization (EUA) in India from the ongoing discussions with the Indian government. 

The campany has also mentioned it is very much committed to bring it's single-dose COVID-19 vaccine to India.

"On August 5, 2021 Johnson & Johnson Pvt Ltd applied for EUA of its single-dose COVID-19 vaccine to the government of India," a Johnson & Johnson India spokesperson said in a statement.

This is an important milestone that paves the way for bringing the company's single-dose COVID-19 vaccine to the people of India, and the rest of the world, through a collaboration with Biological E Limited, the statement added.

"Biological E will be an important part of our global supply chain network, helping to supply our Johnson & Johnson COVID-19 vaccine through the extensive collaborations and partnerships we have with governments, health authorities and organisations such as Gavi and the COVAX Facility," the statement said.

The EUA submission is based on topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, which demonstrated that company's single-shot vaccine was 85 per cent effective in preventing severe disease across all regions studied, and showed protection against COVID-19 related hospitalisation and death, beginning 28 days after vaccination, it added.

"We look forward to concluding our discussions with the government of India to accelerate availability of our COVID-19 vaccine to help end the pandemic," the statement said.

India recorded 44,643 new coronavirus infections taking the total tally of COVID-19 cases to 3,18,56,757, while the active cases registered an increase for the third consecutive day, according to the Union Health Ministry data updated on Friday. The death toll climbed to 4,26,754 with 464 fresh fatalities. 

(With PTI Inputs)

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

How Parag Agrawal Obsessively Focused On Controlling Hate Speech As Twitter CTO

How Parag Agrawal Obsessively Focused On Controlling Hate Speech As Twitter CTO

After taking over as CTO of Twitter, Parag Agrawal’s main focus was on using AI and ML to identify hate speech and bots that were used to spread misinformation through the microblogging site.

'Omicron Virus' Or 'South Africa Variant'? Here's What Not To Call New Covid-19 Strain

'Omicron Virus' Or 'South Africa Variant'? Here's What Not To Call New Covid-19 Strain

The Omicron variant of Covid-19 has led to several discussions on WHO's method of naming virus variants on Greek alphabets. But terms like 'South Africa virus' have remained in use.

IPL 2022 Retention: Who Stays And Who Goes - Full List

IPL 2022 Retention: Who Stays And Who Goes - Full List

IPL Retention list was replete with full of expected names but there were some big omissions too. The mega auction will have a massive pool of stars that teams can now choose from.

Kashmir: Why Is BJP Predicting Doomsday For J&K 2 Years After Article 370 Abrogation

Kashmir: Why Is BJP Predicting Doomsday For J&K 2 Years After Article 370 Abrogation

The statement, issued by senior BJP leader of J&K Ashwani Kumar Chrungoo, raises concern for minorities living in Kashmir Valley.

Advertisement